Ludwig, H; Kasparu, H; Leitgeb, C; Greil, R; Rauch, E; Linkesch, W; Zojer, N; Pour, L; Fillitz, M; Adam, Z.
Impact of number of previous treatment lines and pre-treatment with Bortezomib or Lenalidomid on efficacy of Bortezomib-Bendamustin-Dexamethasone (BBD) in patients with relapsed/refractory Multiple Myeloma (MM).
Annals of Oncology. 2012; 23(9):348-349.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 )
[Oral Communication]
Web of Science